The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Page 85

More JCP Articles

JCP
Clinical and Practical Psychopharmacology

February 4, 2020

In this article, Dr Andrade provides readers with an understanding of how to critically read a recent study of transcranial direct current stimulation for schizophrenia and demonstrates the importance…
JCP
Original Research

February 4, 2020

Persons with mental illness often are excluded from research despite experiencing morbidity and mortality due to the conditions being studied. This report examines the exclusion of suicidal persons from…
, ,
JCP
Publisher’s Note

January 28, 2020

In this publisher’s note, Dr John Shelton reflects on JCP’s progress over the last 10 years.
JCP
Letter to the Editor

January 28, 2020

 Rosenblat and McIntyre reply to the letter “Sublingual Ketamine: An Option for Increasing Accessibility of Ketamine Treatments for Depression?” by Swainson and Khullar.
,
JCP
Academic Highlights

January 28, 2020

Review highlights from 2 experts’ presentations on identifying and treating tardive dyskinesia. Quotes from actual patients illustrate the embarrassment that they feel and show why even mild movements should…
,
JCP
Consensus Statement

January 28, 2020

Tardive dyskinesia remains a serious complication associated with dopamine receptor blocking agents. In this article, read guidance from experts on best practices for tardive dyskinesia screening, diagnosis, and treatment.
, , , et al
JCP
Letter to the Editor

January 28, 2020

In this letter, doctors describe their experiences with use of sublingual ketamine in a clinical setting and possible us of it as a treatment for depression.
,
JCP
Educational Activity

January 28, 2020

After so many years of having inadequate treatment options, you can finally offer patients with tardive dyskinesia approved medications that reduce symptoms. Follow along as expert Dr Leslie Citrome…
JCP
Clinical and Practical Psychopharmacology

January 21, 2020

In this month’s column, Dr Andrade discusses a recent study suggesting that angiotensin receptor blockers are associated with suicide risk. This critical examination of the study will help readers…
JCP
Meta-Analysis

January 21, 2020

Evidence for an effect of exercise on depression in older adults is scant and heterogeneous. This meta-analysis included trials with a specific exercise dose and assessed sources of heterogeneity—read…
, , , et al
JCP
Original Research

January 21, 2020

Learn about the potential risk factors for postpartum depression in patients with past psychiatric conditions.
, , , et al
JCP
Original Research

January 21, 2020

Subthreshold posttraumatic stress disorder (PTSD) may lead to symptoms and functional impairment comparable to those of full PTSD. This study examined the burden of subthreshold PTSD in World Trade…
, , , et al

Expert Consensus on Aripiprazole LAIs in Clinical Practice

Read the full report
Figure. Image of a syringe on two vials highlights aripiprazole monohydrate LAI clinical use in Bipolar I Disorder.

Subscribe to read
more articles

Subscribe